Fig. 1From: P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signalingChronological scheme of the experimental design. a Timeline for OC development and period of P-MAPA and CIS therapy (days). b The schematic protocol used for P-MAPA and CIS administration (twice a week: 9–10 h)Back to article page